Historical salary details - Dr. John M. Maraganore,PhD, Independent Director, Takeda Pharmaceutical Co - ADR
Dr. John M. Maraganore,PhD is the Independent Director of Takeda Pharmaceutical Co - ADR. They also hold 4 other positions in ProKidney Corp - Ordinary Shares - Class A, Rapport Therapeutics Inc., Kymera Therapeutics Inc and Beam Therapeutics Inc.
Dr. John M. Maraganore,Phd
Independent Director
$ 39.0 M
Gross Remuneration
-
Current Company
Takeda Pharmaceutical Co - ADR
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Takeda Pharmaceutical Co - ADR | Independent Director | 39 M | 21.9 % |
| 2024 | ProKidney Corp - Ordinary Shares - Class A | Independent Director | 31 K | -92.6 % |
| 2024 | Rapport Therapeutics Inc. | Director | - | - |
| 2024 | Kymera Therapeutics Inc | Independent Director | - | - |
| 2024 | Beam Therapeutics Inc | Independent Director | - | - |
| 2023 | Takeda Pharmaceutical Co - ADR | Independent Director | 32 M | - |
| 2023 | Beam Therapeutics Inc | Independent Director | 435.2 K | 1.6 % |
| 2023 | ProKidney Corp - Ordinary Shares - Class A | Independent Director | 420.1 K | -90.3 % |
| 2023 | Kymera Therapeutics Inc | Independent Director | 236.5 K | - |
| 2023 | Agios Pharmaceuticals Inc | Lead Independent Director | 59.7 K | -86.8 % |
| 2022 | ProKidney Corp - Ordinary Shares - Class A | Independent Director | 4.4 M | - |
| 2022 | Agios Pharmaceuticals Inc | Lead Independent Director | 452.3 K | -0.0 % |
| 2022 | Beam Therapeutics Inc | Independent Director | 428.2 K | -44.8 % |
| 2022 | Kymera Therapeutics Inc | Independent Director | - | - |
| 2022 | Takeda Pharmaceutical Co - ADR | Independent Director | - | - |
| 2021 | Beam Therapeutics Inc | Independent Director | 776.2 K | - |
| 2021 | Agios Pharmaceuticals Inc | Lead Independent Director | 452.4 K | -0.0 % |
| 2021 | ProKidney Corp - Ordinary Shares - Class A | Director | - | - |
| 2021 | Alnylam Pharmaceuticals Inc | Director and Chief Executive Officer | - | - |
| 2021 | Kymera Therapeutics Inc | Independent Director | - | - |
| 2020 | Agios Pharmaceuticals Inc | Lead Independent Director | 452.5 K | 0.0 % |
| 2020 | Alnylam Pharmaceuticals Inc | Director and Chief Executive Officer | - | - |
| 2019 | Agios Pharmaceuticals Inc | Lead Independent Director | 452.4 K | -22.2 % |
| 2019 | Alnylam Pharmaceuticals Inc | Director and Chief Executive Officer | - | - |
| 2018 | Agios Pharmaceuticals Inc | Lead Independent Director | 581.6 K | 64.2 % |
| 2018 | Alnylam Pharmaceuticals Inc | Director and Chief Executive Officer | - | - |
| 2017 | Bluebird bio Inc | - | 429.2 K | 88.6 % |
| 2017 | Agios Pharmaceuticals Inc | Chairman of the Board | 354.3 K | 17.2 % |
| 2017 | Alnylam Pharmaceuticals Inc | Chief Executive Officer and Director | - | - |
| 2017 | Bluebird bio Inc | Independent Director | - | - |
| 2016 | Agios Pharmaceuticals Inc | Chairman of the Board | 302.3 K | -73.7 % |
| 2016 | Bluebird bio Inc | Independent Director | 227.5 K | -75.0 % |
| 2016 | Alnylam Pharmaceuticals Inc | Chief Executive Officer and Director | - | - |
| 2015 | Agios Pharmaceuticals Inc | Independent Director | 1.1 M | 248.0 % |
| 2015 | Bluebird bio Inc | Independent Director | 909.5 K | 458.0 % |
| 2015 | Alnylam Pharmaceuticals Inc | Chief Executive Officer and Director | - | - |
| 2014 | Agios Pharmaceuticals Inc | Independent Director | 330.0 K | 91.7 % |
| 2014 | Bluebird bio Inc | Independent Director | 163.0 K | 71.7 % |
| 2014 | Regulus Therapeutics Inc | - | 72.8 K | - |
| 2014 | Regulus Therapeutics Inc | Director | - | - |
| 2014 | Alnylam Pharmaceuticals Inc | Chief Executive Officer and Director | - | - |
| 2013 | Agios Pharmaceuticals Inc | Independent Director | 172.2 K | 123.2 % |
| 2013 | Bluebird bio Inc | Independent Director | 94.9 K | 24.1 % |
| 2013 | Alnylam Pharmaceuticals Inc | Chief Executive Officer and Director | - | - |
| 2013 | Regulus Therapeutics Inc | Director | - | - |
| 2012 | Agios Pharmaceuticals Inc | Independent Director | 77.1 K | - |
| 2012 | Bluebird bio Inc | Director | 76.5 K | - |
| 2012 | Alnylam Pharmaceuticals Inc | Chief Executive Officer and Director | - | - |
| 2012 | Regulus Therapeutics Inc | Chairman of the Board | - | - |
| 2011 | Alnylam Pharmaceuticals Inc | Chief Executive Officer and Director | - | - |
| 2011 | Regulus Therapeutics Inc | Chairman of the Board | - | - |
| 2010 | Alnylam Pharmaceuticals Inc | Chief Executive Officer and Director | - | - |
| 2009 | Alnylam Pharmaceuticals Inc | Chief Executive Officer and Director | - | - |
| 2008 | Alnylam Pharmaceuticals Inc | Chief Executive Officer and Director | - | - |
| 2007 | Alnylam Pharmaceuticals Inc | Chief Executive Officer and Director | - | - |
| 2006 | Alnylam Pharmaceuticals Inc | Chief Executive Officer and Director | - | - |
| 2005 | Alnylam Pharmaceuticals Inc | President, Chief Executive Officer and Director | - | - |
| 2004 | Alnylam Pharmaceuticals Inc | President, Chief Executive Officer and Director | - | - |
| 2003 | Alnylam Pharmaceuticals Inc | President, Chief Executive Officer and Director | - | - |